Withdrawal of Registration Statement (rw)
23 Agosto 2017 - 11:10AM
Edgar (US Regulatory)
Accelerated Pharma, Inc.
36 Church Lane
Westport, Connecticut 06880
Application for Withdrawal of Registration
Statement
August 23, 2017
U.S. Securities and Exchange Commission
Division of Corporation Finance
Washington, D.C. 20549
Registration
Statement on Form S-1
Filed
on July 12, 2017
File No. 333-214048
Ladies and Gentlemen:
Pursuant to Rule 477 under the Securities Act of 1933, as amended
(the “Act”), Accelerated Pharma, Inc.(the “Company”) hereby requests the withdrawal of the Company’s
registration statement on Form S-1, the most recent amendment of which was filed with the United States Securities and Exchange
Commission (the “SEC”) on July 12, 2017. The Company requests the withdrawal of the registration statement because
the Company has decided not to proceed with this underwritten offering. The registration statement has not been declared effective
and no shares of the Company’s common stock or other securities have been sold under the registration statement.
The Company requests that, in accordance with Rule 457(p) under
the Act, all fees paid to the SEC in connection with the filing of the registration statement be credited for future use.
If you have any questions with respect to this matter, please
call the Office of Richard Rubin, at 917-957-9092. Thank you for your assistance in this matter.
Respectfully submitted,
/s/: Michael Fonstein, PhD.
Michael Fonstein, CEO
ACCELERATED PHARMA, INC. (NASDAQ:ACCP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
ACCELERATED PHARMA, INC. (NASDAQ:ACCP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Accelerated Pharma (MM) (NASDAQ): 0 recent articles
Más de Accelerated Pharma, Inc. Artículos de Noticias